AI summary Trust: medium Third-party lab

Janoshik performed qualitative and quantitative analysis on this NAD+ sample, dated January 30, 2026. The tested quantity showed multiple readings (544.41 mg, 552.94 mg, 565.94 mg) against a 500mg label. Purity and endotoxin results are not available on this report. The test is recent (3-6 months old), and customers can cross-check on the lab's public verification URL.

Watch out for
  • no purity test
  • no endotoxin test
  • multiple quantity readings
Test date
2026-01-30
Purity
—
Batch / lot
—
Lab
Janoshik
Quantity
label 500mg tested 544.41 mg; 552.94 mg; 565.94 mg
Qty vs label
—
Endotoxins
—
Test score
—
Manufacturer
GYC
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Janoshik (public)

✓ Artifact captured

We have the certificate image — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
Qualitative and quantitative analysis (non-AAS)
Dose
500mg
Catalogued
2026-04-16
OCR text

Raw extracted text

Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display. 

{
  "peptide": "NAD",
  "dose": "500mg",
  "purity_pct": null,
  "purity_label": "",
  "method": "Qualitative and quantitative analysis of non-AAS sample.",
  "test_date": "2026-01-30",
  "client": "G",
  "notes": "",
  "label_qty": "500mg",
  "tested_qty": "544.41 mg; 552.94 mg; 565.94 mg",
  "quantity_deviation_pct": null,
  "is_blend": false,
  "components_json": "",
  "ocr_confidence": 1.0
}
This COA is part of TitrateLab's community-trust corpus. See more from GYC or learn how trust scores are computed on the methodology page.